Abacavir/Lamivudină Mylan

Abacavir/Lamivudina Mylan is a combination medication used in the treatment of HIV infection. This oral medication is designed to help manage the virus and improve immune function.

Abacavir/Lamivudina Mylan is primarily used in the management of HIV infection. This combination medication works by reducing the amount of HIV in the body, which helps to improve immune function and reduce the risk of HIV-related complications. It is often used as part of a broader treatment plan that includes other medications and lifestyle changes.

Common effects of Abacavir/Lamivudina Mylan may include headache, nausea, and fatigue. Some individuals may also experience dizziness or difficulty sleeping. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Abacavir/Lamivudina Mylan should be used with caution in individuals with a history of liver or kidney problems. It is important to follow the prescribed dosage and to inform your healthcare provider of any other medications you are taking. Regular monitoring of liver function may be recommended during treatment.

Abacavir/Lamivudina Mylan may interact with other medications, including certain antiviral drugs and medications that affect liver enzymes. It is important to inform your healthcare provider of all medications you are taking to avoid potential interactions. Alcohol consumption should be limited, as it may exacerbate side effects.